# Vistagen Therapeutics, Inc.: filings

VTGN · Nasdaq · CIK 1411685 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/vtgn.md) · [Financials](/companies/vtgn/financials.md) · [Filings](/companies/vtgn/filings.md) · [Insiders](/companies/vtgn/insiders.md)

## Reports and events: 388 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 268, 4 249, 10-Q 53, SC 13G/A 35, CORRESP 30, 3 28, SC 13G 26, UPLOAD 21, SCHEDULE 13G/A 20, 10-K 18, DEF 14A 15, 424B5 13, DEFA14A 12, EFFECT 12, S-1/A 11, D 8, 8-K/A 7, PRE 14A 7, S-3 6, S-1 5, S-3/A 5, S-8 5, 10-Q/A 4, CT ORDER 4, SC 13D 4, 424B3 3, 424B4 3, NT 10-Q 3, SCHEDULE 13G 3, 3/A 2, 4/A 2, FWP 2, NT 10-K 2, SC 13D/A 2, 10-K/A 1, 5 1, 8-A12B 1, 8-A12G 1, CERTNAS 1, POS AM 1, PRER14A 1, RW 1, S-8 POS 1, SC 14F1 1, SC 14F1/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 17:24 ET | [8-K](/filings/0001628280-26-068627.md) | 2.05 Exit or disposal costs; 8.01 Other events | 0001628280-26-068627 |
| 2026-10-09 | 17:15 ET | [8-K](/filings/0001628280-26-065559.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-065559 |
| 2026-09-25 | 09:11 ET | [8-K](/filings/0001628280-26-063510.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-063510 |
| 2026-09-24 | 07:05 ET | [8-K](/filings/0001628280-26-063316.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-063316 |
| 2026-09-22 | 16:22 ET | [8-K](/filings/0001628280-26-063046.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-063046 |
| 2026-09-11 | 19:24 ET | [8-K](/filings/0001628280-26-061445.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-26-061445 |
| 2026-08-14 | 16:12 ET | [10-Q](/filings/0001628280-26-057116.md) | Quarterly report, period 2026-06-30 | 0001628280-26-057116 |
| 2026-08-14 | 08:40 ET | [8-K](/filings/0001628280-26-056953.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-056953 |
| 2026-08-06 | 16:16 ET | [8-K](/filings/0001628280-26-054341.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-054341 |
| 2026-08-05 | 16:04 ET | [8-K](/filings/0001628280-26-053304.md) | 3.01 Delisting notice | 0001628280-26-053304 |
| 2026-07-31 | 16:10 ET | [DEF 14A](/filings/0001628280-26-051404.md) | Proxy statement, period 2026-07-31 | 0001628280-26-051404 |
| 2026-07-31 | 08:48 ET | [8-K](/filings/0001628280-26-051251.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-051251 |
| 2026-06-30 | 08:28 ET | [8-K](/filings/0001628280-26-046143.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-046143 |
| 2026-06-17 | 17:13 ET | [8-K](/filings/0001628280-26-043989.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-043989 |
| 2026-06-15 | 16:50 ET | [10-K](/filings/0001628280-26-043271.md) | Annual report, period 2026-03-31 | 0001628280-26-043271 |
| 2026-06-15 | 16:35 ET | [8-K](/filings/0001628280-26-043232.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-043232 |
| 2026-06-09 | 17:04 ET | [8-K](/filings/0001628280-26-041962.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-041962 |
| 2026-05-19 | 16:30 ET | [8-K](/filings/0001628280-26-036492.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-036492 |
| 2026-05-12 | 07:44 ET | [8-K](/filings/0001628280-26-033883.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-033883 |
| 2026-05-08 | 16:30 ET | [8-K](/filings/0001628280-26-032935.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-032935 |
| 2026-04-28 | 16:13 ET | [8-K](/filings/0001628280-26-027930.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-027930 |
| 2026-04-13 | 17:27 ET | [8-K](/filings/0001628280-26-024943.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-024943 |
| 2026-04-02 | 16:16 ET | [8-K](/filings/0001628280-26-023176.md) | 3.01 Delisting notice | 0001628280-26-023176 |
| 2026-03-18 | 16:45 ET | [8-K](/filings/0001628280-26-019455.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-019455 |
| 2026-03-16 | 16:10 ET | [8-K](/filings/0001628280-26-018163.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-018163 |
| 2026-03-11 | 07:02 ET | [8-K](/filings/0001628280-26-016652.md) | 8.01 Other events | 0001628280-26-016652 |
| 2026-02-20 | 09:12 ET | [8-K](/filings/0001628280-26-010035.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-010035 |
| 2026-02-12 | 16:38 ET | [10-Q](/filings/0001628280-26-007718.md) | Quarterly report, period 2025-12-31 | 0001628280-26-007718 |
| 2026-02-12 | 16:35 ET | [8-K](/filings/0001628280-26-007715.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-007715 |
| 2026-02-06 | 16:12 ET | [8-K](/filings/0001628280-26-006078.md) | 3.01 Delisting notice | 0001628280-26-006078 |
| 2026-01-09 | 17:26 ET | [8-K](/filings/0001628280-26-001690.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-001690 |
| 2025-12-22 | 17:29 ET | [8-K](/filings/0001628280-25-058594.md) | 8.01 Other events | 0001628280-25-058594 |
| 2025-12-03 | 16:47 ET | [8-K](/filings/0001628280-25-055083.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-055083 |
| 2025-11-13 | 16:35 ET | [10-Q](/filings/0001628280-25-052079.md) | Quarterly report, period 2025-09-30 | 0001628280-25-052079 |
| 2025-11-13 | 16:34 ET | [8-K](/filings/0001628280-25-052077.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-052077 |
| 2025-11-04 | 16:10 ET | [8-K](/filings/0001628280-25-048827.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-048827 |
| 2025-10-29 | 17:24 ET | [8-K](/filings/0001628280-25-047188.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-047188 |
| 2025-09-15 | 16:50 ET | [8-K](/filings/0001411685-25-000081.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001411685-25-000081 |
| 2025-08-07 | 16:57 ET | [10-Q](/filings/0001411685-25-000064.md) | Quarterly report, period 2025-06-30 | 0001411685-25-000064 |
| 2025-08-07 | 16:56 ET | [8-K](/filings/0001411685-25-000062.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001411685-25-000062 |
| 2025-07-28 | 17:14 ET | [DEF 14A](/filings/0001411685-25-000052.md) | Proxy statement, period 2025-09-09 | 0001411685-25-000052 |
| 2025-06-25 | 16:59 ET | [8-K](/filings/0001411685-25-000048.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001411685-25-000048 |
| 2025-06-17 | 16:44 ET | [8-K](/filings/0001411685-25-000046.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001411685-25-000046 |
| 2025-06-17 | 16:35 ET | [10-K](/filings/0001411685-25-000041.md) | Annual report, period 2025-03-31 | 0001411685-25-000041 |
| 2025-06-02 | 16:35 ET | [8-K](/filings/0001411685-25-000028.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001411685-25-000028 |
| 2025-03-06 | 16:51 ET | [8-K](/filings/0001411685-25-000023.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001411685-25-000023 |
| 2025-02-13 | 17:25 ET | [10-Q](/filings/0001411685-25-000019.md) | Quarterly report, period 2024-12-31 | 0001411685-25-000019 |
| 2025-02-13 | 16:45 ET | [8-K](/filings/0001411685-25-000017.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001411685-25-000017 |
| 2025-02-05 | 17:04 ET | [8-K](/filings/0001411685-25-000011.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001411685-25-000011 |
| 2025-01-14 | 17:16 ET | [8-K](/filings/0001411685-25-000007.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001411685-25-000007 |

Page 1 of 8. [Older](/companies/vtgn/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 17:32 ET. No prices; not investment advice.